Catalyst Crew Technologies Corp. (OTC: CCTC) announced it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval to change its corporate name to LataMed AI Corp. and to adopt a new trading symbol. The proposed changes aim to better align the company's public identity with its strategic focus on artificial intelligence-enabled healthcare technology, including healthcare analytics and technology-enabled healthcare services infrastructure, with an initial emphasis on Latin America.
The corporate action was approved by the Company's Board of Directors and by written consent of the majority shareholder in accordance with Nevada law. Importantly, the proposed changes do not involve any reverse stock split, forward stock split, recapitalization, change to authorized capital, or other modification to the Company's capital structure. The issued and outstanding share count will remain unchanged, and shareholders will not need to take any action.
Upon FINRA approval, the Company intends to file a Certificate of Amendment with the Nevada Secretary of State to effect the name change. The name and symbol change would become effective after the required corporate filings and publication by FINRA on the Daily List. There is no assurance that FINRA will approve the proposed changes or as to the timing of any such approval.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: “There is no change to the Company’s capital structure as part of this process. This proposed name change is intended to better align the Company’s public identity with its healthcare technology strategy and long-term market focus.”
The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. For more information, visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This press release contains forward-looking statements that involve risks and uncertainties, including the Company's ability to successfully implement its business plan, secure financing, complete acquisitions, and obtain regulatory approvals. The Company is a development-stage enterprise and has not generated revenues from its newly announced business direction. Prospective investors are urged to review all risk factors in the Company's SEC filings.
